Selvamurthi Gomathi
Overview
Explore the profile of Selvamurthi Gomathi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sivamalar S, Gomathi S, Boobalan J, Balakrishnan P, Pradeep A, Devaraj C, et al.
Indian J Med Microbiol
. 2023 Dec;
47:100520.
PMID: 38052366
Purpose: HIV-1 Drug Resistance Mutations (DRMs) among Immunological failure (IF) on NRTI based first-line regimens, Thymidine analogue (TA) - AZT & D4T and Non-Thymidine Analogue (NTA) -TDF; and predict viral...
2.
Clipman S, Solomon S, Srikrishnan A, McFall A, Gomathi S, Saravanan S, et al.
Open Forum Infect Dis
. 2022 Oct;
9(10):ofac481.
PMID: 36225747
Background: Drug resistance testing is limited in public-sector human immunodeficiency virus (HIV) care in India, and there are few systematic samplings for prevalent drug resistance mutations (DRMs), particularly among men...
3.
Rodgers M, Gomathi S, Vallari A, Saravanan S, Lucas G, Mehta S, et al.
Sci Rep
. 2020 May;
10(1):7214.
PMID: 32350342
Although the prevalences of HIV and HCV are significantly higher amongst PWID in India compared to the general population, the strains circulating within this group have not been well-characterized. Through...
4.
Saravanan S, Gomathi S, DeLong A, Kausalya B, Sivamalar S, Poongulali S, et al.
J Antimicrob Chemother
. 2018 May;
73(8):2152-2161.
PMID: 29800305
Objectives: Examine HIV-1 plasma viral load (PVL) and genital tract (GT) viral load (GVL) and drug resistance in India. Methods: At the YRG Centre for AIDS Research and Education, Chennai,...
5.
Saravanan S, Kausalya B, Gomathi S, Sivamalar S, Pachamuthu B, Selvamuthu P, et al.
AIDS Res Hum Retroviruses
. 2016 Nov;
33(6):567-574.
PMID: 27869478
We have analyzed reverse transcriptase (RT) region of HIV-1 pol gene from 97 HIV-infected children who were identified as failing first-line therapy that included first-generation non-nucleoside RT inhibitors (Nevirapine and...
6.
Sivamalar S, Dinesha T, Gomathi S, Pradeep A, Boobalan J, Solomon S, et al.
AIDS Res Hum Retroviruses
. 2016 Jul;
33(3):271-274.
PMID: 27460519
Lack of HIV-1 viral load monitoring in resource-limited settings leads to the development of HIV drug resistance mutations, although WHO recommends viral load testing for monitoring as this helps in...
7.
Dinesha T, Gomathi S, Boobalan J, Sivamalar S, Solomon S, Pradeep A, et al.
AIDS Res Hum Retroviruses
. 2016 Jun;
32(12):1234-1236.
PMID: 27334566
According to 2013 WHO guidelines, tenofovir (TDF) is the preferred first-line regimen for adults and adolescents. A total of 167 HIV-1-infected patients attaining immunological failure after TDF-based first-line HAART were...
8.
Saravanan S, Gomathi S, Kausalya B, Boobalan J, Murugavel K, Balakrishnan P, et al.
AIDS Res Hum Retroviruses
. 2015 Apr;
31(6):655-7.
PMID: 25839730
In this study HIV-1 subtype C-infected adults demonstrated higher purifying selection on their viral populations in reverse transcriptase (RT) than infected children. This difference is likely explained by more mature...
9.
Saravanan S, Madhavan V, Kantor R, Sivamalar S, Gomathi S, Solomon S, et al.
AIDS Res Hum Retroviruses
. 2012 Mar;
28(12):1763-5.
PMID: 22404052
We report a high frequency of drug resistance mutations among patients with unusual insertions or deletions at the β(3)-β(4) hairpin-loop-coding region of HIV-1 subtype C reverse transcriptase, during failure of...